• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

14/11/2025 17:46

Omkar Pharmachem - Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th November, 2025

Dear Sir, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in their meeting held on 14th November, 2025 has considered and approved the following business: 1. Unaudited Financial Results of the Company for the quarter and half yearly ended on 30th September, 2025